Rank | Gene Set | Z-score |
---|---|---|
1 | muscle filament sliding (GO:0030049) | 8.35840132 |
2 | actin-myosin filament sliding (GO:0033275) | 8.35840132 |
3 | regulation of skeletal muscle contraction (GO:0014819) | 7.80169780 |
4 | carnitine shuttle (GO:0006853) | 7.55226322 |
5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.31161597 |
6 | sarcomere organization (GO:0045214) | 6.86190658 |
7 | actin-mediated cell contraction (GO:0070252) | 6.82060489 |
8 | fatty acid transmembrane transport (GO:1902001) | 6.71942907 |
9 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.69205933 |
10 | skeletal muscle adaptation (GO:0043501) | 6.61307477 |
11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.55240956 |
12 | skeletal muscle contraction (GO:0003009) | 6.29051323 |
13 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 6.09989068 |
14 | tricarboxylic acid cycle (GO:0006099) | 6.05623810 |
15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.85431595 |
16 | myofibril assembly (GO:0030239) | 5.80990357 |
17 | regulation of sequestering of triglyceride (GO:0010889) | 5.70961548 |
18 | carnitine transmembrane transport (GO:1902603) | 5.70823921 |
19 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.68517211 |
20 | plasma membrane repair (GO:0001778) | 5.61788553 |
21 | regulation of cofactor metabolic process (GO:0051193) | 5.55048903 |
22 | regulation of coenzyme metabolic process (GO:0051196) | 5.55048903 |
23 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.36924394 |
24 | carnitine transport (GO:0015879) | 5.20322338 |
25 | amino-acid betaine transport (GO:0015838) | 5.20322338 |
26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.19732862 |
27 | creatine metabolic process (GO:0006600) | 5.19440217 |
28 | striated muscle contraction (GO:0006941) | 5.19252013 |
29 | regulation of cell communication by electrical coupling (GO:0010649) | 5.16410510 |
30 | actin filament-based movement (GO:0030048) | 5.13477201 |
31 | cardiac myofibril assembly (GO:0055003) | 5.00385855 |
32 | skeletal muscle tissue development (GO:0007519) | 4.92913611 |
33 | glycogen catabolic process (GO:0005980) | 4.82069416 |
34 | striated muscle atrophy (GO:0014891) | 4.76208428 |
35 | cardiac muscle contraction (GO:0060048) | 4.73352496 |
36 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.73343247 |
37 | regulation of relaxation of muscle (GO:1901077) | 4.72144901 |
38 | regulation of actin filament-based movement (GO:1903115) | 4.50948065 |
39 | regulation of sulfur metabolic process (GO:0042762) | 4.50409918 |
40 | glucan catabolic process (GO:0009251) | 4.49304783 |
41 | fructose metabolic process (GO:0006000) | 4.48836163 |
42 | NADH metabolic process (GO:0006734) | 4.41692504 |
43 | actomyosin structure organization (GO:0031032) | 4.40262721 |
44 | regulation of fatty acid oxidation (GO:0046320) | 4.34898042 |
45 | positive regulation of myotube differentiation (GO:0010831) | 4.32100865 |
46 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.29042423 |
47 | muscle cell cellular homeostasis (GO:0046716) | 4.27032890 |
48 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.25189397 |
49 | muscle organ morphogenesis (GO:0048644) | 4.23337984 |
50 | cellular polysaccharide catabolic process (GO:0044247) | 4.16579407 |
51 | muscle cell fate commitment (GO:0042693) | 4.14626334 |
52 | striated muscle adaptation (GO:0014888) | 4.09800463 |
53 | muscle contraction (GO:0006936) | 4.09447045 |
54 | glycogen biosynthetic process (GO:0005978) | 4.08194442 |
55 | glucan biosynthetic process (GO:0009250) | 4.08194442 |
56 | biotin metabolic process (GO:0006768) | 4.06610704 |
57 | muscle atrophy (GO:0014889) | 4.05536787 |
58 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03377697 |
59 | response to inactivity (GO:0014854) | 4.03135473 |
60 | gluconeogenesis (GO:0006094) | 4.03048296 |
61 | fatty acid beta-oxidation (GO:0006635) | 3.99555061 |
62 | cardiac muscle cell development (GO:0055013) | 3.93938657 |
63 | intracellular lipid transport (GO:0032365) | 3.92945684 |
64 | polysaccharide catabolic process (GO:0000272) | 3.92055428 |
65 | muscle structure development (GO:0061061) | 3.90352786 |
66 | muscle organ development (GO:0007517) | 3.90175781 |
67 | muscle hypertrophy (GO:0014896) | 3.86533198 |
68 | response to muscle activity (GO:0014850) | 3.75559601 |
69 | succinate metabolic process (GO:0006105) | 3.75181640 |
70 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.74697781 |
71 | valine metabolic process (GO:0006573) | 3.73514727 |
72 | skeletal muscle fiber development (GO:0048741) | 3.72274809 |
73 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.71432968 |
74 | muscle system process (GO:0003012) | 3.70530117 |
75 | positive regulation of fatty acid oxidation (GO:0046321) | 3.70094612 |
76 | quaternary ammonium group transport (GO:0015697) | 3.68330518 |
77 | cardiac cell development (GO:0055006) | 3.68006367 |
78 | regulation of striated muscle contraction (GO:0006942) | 3.67145115 |
79 | myoblast fusion (GO:0007520) | 3.66169383 |
80 | IMP metabolic process (GO:0046040) | 3.62628297 |
81 | hexose biosynthetic process (GO:0019319) | 3.60082342 |
82 | * response to activity (GO:0014823) | 3.59371439 |
83 | heart process (GO:0003015) | 3.57489515 |
84 | heart contraction (GO:0060047) | 3.57489515 |
85 | neuronal action potential propagation (GO:0019227) | 3.55905210 |
86 | skeletal muscle tissue regeneration (GO:0043403) | 3.54110118 |
87 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.53506634 |
88 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.51858172 |
89 | glycogen metabolic process (GO:0005977) | 3.51557765 |
90 | lipid particle organization (GO:0034389) | 3.49604739 |
91 | cellular carbohydrate catabolic process (GO:0044275) | 3.49576843 |
92 | negative regulation of muscle contraction (GO:0045932) | 3.49426959 |
93 | myotube differentiation (GO:0014902) | 3.49394663 |
94 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.46326817 |
95 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.44400397 |
96 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.44400397 |
97 | glucan metabolic process (GO:0044042) | 3.43941923 |
98 | cellular glucan metabolic process (GO:0006073) | 3.43941923 |
99 | tricarboxylic acid metabolic process (GO:0072350) | 3.43870135 |
100 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.43580670 |
101 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.42525956 |
102 | cardiac muscle adaptation (GO:0014887) | 3.41041195 |
103 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.41041195 |
104 | muscle hypertrophy in response to stress (GO:0003299) | 3.41041195 |
105 | muscle adaptation (GO:0043500) | 3.39050922 |
106 | striated muscle hypertrophy (GO:0014897) | 3.36523351 |
107 | muscle fiber development (GO:0048747) | 3.35685832 |
108 | adult heart development (GO:0007512) | 3.34897279 |
109 | fatty acid catabolic process (GO:0009062) | 3.34489224 |
110 | cardiac muscle hypertrophy (GO:0003300) | 3.34412928 |
111 | acetyl-CoA metabolic process (GO:0006084) | 3.32624935 |
112 | regulation of membrane repolarization (GO:0060306) | 3.32274398 |
113 | neuromuscular synaptic transmission (GO:0007274) | 3.31292140 |
114 | negative regulation of necroptotic process (GO:0060546) | 3.30453762 |
115 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.27743066 |
116 | striated muscle tissue development (GO:0014706) | 3.27287249 |
117 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.25758593 |
118 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.23949113 |
119 | muscle cell development (GO:0055001) | 3.23784279 |
120 | ubiquinone biosynthetic process (GO:0006744) | 3.23009069 |
121 | myotube cell development (GO:0014904) | 3.22392680 |
122 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.22363063 |
123 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.22363063 |
124 | skeletal muscle cell differentiation (GO:0035914) | 3.21637832 |
125 | fatty acid oxidation (GO:0019395) | 3.21202606 |
126 | lipid oxidation (GO:0034440) | 3.20863629 |
127 | regulation of myoblast differentiation (GO:0045661) | 3.20605564 |
128 | branched-chain amino acid catabolic process (GO:0009083) | 3.18929165 |
129 | AMP metabolic process (GO:0046033) | 3.17877314 |
130 | relaxation of muscle (GO:0090075) | 3.17830620 |
131 | oxaloacetate metabolic process (GO:0006107) | 3.16719478 |
132 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.16290479 |
133 | positive regulation of cation channel activity (GO:2001259) | 3.15366248 |
134 | muscle tissue morphogenesis (GO:0060415) | 3.11029263 |
135 | branched-chain amino acid metabolic process (GO:0009081) | 3.10659679 |
136 | striated muscle cell development (GO:0055002) | 3.07863834 |
137 | fatty acid homeostasis (GO:0055089) | 3.04527178 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.03793383 |
2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.09074933 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.71188981 |
4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.25485550 |
5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.96598151 |
6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.96598151 |
7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.85619305 |
8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.72429256 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.71347762 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.69719274 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52835801 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.41549239 |
13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.17753437 |
14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99666650 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98948636 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90050203 |
17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76805450 |
18 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73215952 |
19 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.72030796 |
20 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.69602831 |
21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66861801 |
22 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63287507 |
23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.62421954 |
24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61957932 |
25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61654997 |
26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55070635 |
27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54980611 |
28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.53851392 |
29 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.53420203 |
30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.46644350 |
31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46297938 |
32 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.39000565 |
33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35200828 |
34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34117708 |
35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30838342 |
36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30247817 |
37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26919717 |
38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26571331 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26319041 |
40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26249234 |
41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.25942178 |
42 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24542711 |
43 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.23470704 |
44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21053907 |
45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19843253 |
46 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19165729 |
47 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.18587608 |
48 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18582056 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18280908 |
50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17942510 |
51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17497239 |
52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17473667 |
53 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.15060329 |
54 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.13955585 |
55 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.12501550 |
56 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12271999 |
57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11247632 |
58 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.10785542 |
59 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10270818 |
60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09297908 |
61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08962989 |
62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07602952 |
63 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.07589660 |
64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03732125 |
65 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01902024 |
66 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01038432 |
67 | MAF_26560356_Chip-Seq_TH1_Human | 1.00419659 |
68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99708559 |
69 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99600032 |
70 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98011893 |
71 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97806902 |
72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96739824 |
73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96686561 |
74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96592788 |
75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96212897 |
76 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95944956 |
77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95926325 |
78 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95565708 |
79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94751996 |
80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94465918 |
81 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93069036 |
82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92535345 |
83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92249274 |
84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92228044 |
85 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90952562 |
86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89100317 |
87 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89090297 |
88 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88990657 |
89 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.88279895 |
90 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87640884 |
91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.86884744 |
92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86644283 |
93 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86210906 |
94 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85937745 |
95 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85436797 |
96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85235350 |
97 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85172256 |
98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84915357 |
99 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84398939 |
100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84277346 |
101 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.84165476 |
102 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84080411 |
103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84033001 |
104 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83633999 |
105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82593770 |
106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82336621 |
107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82059484 |
108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82039683 |
109 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.81895944 |
110 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81878310 |
111 | P68_20966046_ChIP-Seq_HELA_Human | 0.81875060 |
112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81714716 |
113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80618008 |
114 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80470892 |
115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79556183 |
116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79375872 |
117 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79283481 |
118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79234344 |
119 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.78955201 |
120 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78633391 |
121 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78590433 |
122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78393288 |
123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78393288 |
124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78312665 |
125 | MAF_26560356_Chip-Seq_TH2_Human | 0.78234724 |
126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77965676 |
127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77774559 |
128 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.77530255 |
129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77490630 |
130 | ATF3_27146783_Chip-Seq_COLON_Human | 0.77441534 |
131 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.77196261 |
132 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77067905 |
133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76802190 |
134 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76527855 |
135 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76373581 |
136 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75890833 |
137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75778872 |
138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75741951 |
139 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75627477 |
140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75582712 |
141 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.75244873 |
142 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75070432 |
143 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74900932 |
144 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.74834964 |
145 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.74678882 |
146 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.74564921 |
147 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.74482217 |
148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74416428 |
149 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.74127901 |
150 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72925198 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 6.06816891 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 5.30981478 |
3 | MP0000751_myopathy | 5.21502816 |
4 | MP0004145_abnormal_muscle_electrophysio | 4.95195665 |
5 | MP0000749_muscle_degeneration | 4.74749759 |
6 | MP0004130_abnormal_muscle_cell | 4.19530472 |
7 | MP0004036_abnormal_muscle_relaxation | 3.81789939 |
8 | MP0005451_abnormal_body_composition | 3.66596270 |
9 | MP0004084_abnormal_cardiac_muscle | 3.33534356 |
10 | MP0002106_abnormal_muscle_physiology | 3.26590714 |
11 | MP0004087_abnormal_muscle_fiber | 3.26033495 |
12 | MP0005670_abnormal_white_adipose | 3.09473354 |
13 | MP0004215_abnormal_myocardial_fiber | 3.08132499 |
14 | MP0000750_abnormal_muscle_regeneration | 3.07667905 |
15 | MP0000747_muscle_weakness | 2.98721377 |
16 | MP0005620_abnormal_muscle_contractility | 2.89022626 |
17 | MP0000759_abnormal_skeletal_muscle | 2.88747006 |
18 | MP0002269_muscular_atrophy | 2.87691141 |
19 | MP0005330_cardiomyopathy | 2.85308826 |
20 | MP0005666_abnormal_adipose_tissue | 2.81925225 |
21 | MP0005369_muscle_phenotype | 2.67163556 |
22 | MP0004185_abnormal_adipocyte_glucose | 2.47023185 |
23 | MP0002972_abnormal_cardiac_muscle | 2.20582616 |
24 | MP0004233_abnormal_muscle_weight | 2.06555761 |
25 | MP0005375_adipose_tissue_phenotype | 1.97231082 |
26 | MP0002332_abnormal_exercise_endurance | 1.96619992 |
27 | * MP0006036_abnormal_mitochondrial_physio | 1.93127363 |
28 | MP0010630_abnormal_cardiac_muscle | 1.87180199 |
29 | MP0002971_abnormal_brown_adipose | 1.86976326 |
30 | MP0004484_altered_response_of | 1.86931193 |
31 | MP0001544_abnormal_cardiovascular_syste | 1.82994019 |
32 | MP0005385_cardiovascular_system_phenoty | 1.82994019 |
33 | MP0008775_abnormal_heart_ventricle | 1.79374187 |
34 | MP0003137_abnormal_impulse_conducting | 1.76639389 |
35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.54577568 |
36 | MP0006138_congestive_heart_failure | 1.53081973 |
37 | MP0002108_abnormal_muscle_morphology | 1.42164108 |
38 | MP0000013_abnormal_adipose_tissue | 1.35457256 |
39 | MP0003828_pulmonary_edema | 1.34034177 |
40 | MP0000733_abnormal_muscle_development | 1.31026304 |
41 | MP0003950_abnormal_plasma_membrane | 1.18957628 |
42 | MP0004510_myositis | 1.12401322 |
43 | MP0000003_abnormal_adipose_tissue | 1.11204810 |
44 | MP0004085_abnormal_heartbeat | 1.10561550 |
45 | MP0002822_catalepsy | 1.08982684 |
46 | MP0000343_altered_response_to | 1.06266564 |
47 | MP0003705_abnormal_hypodermis_morpholog | 1.00931741 |
48 | * MP0005334_abnormal_fat_pad | 1.00497021 |
49 | MP0005266_abnormal_metabolism | 0.93255402 |
50 | MP0008961_abnormal_basal_metabolism | 0.93008420 |
51 | MP0005535_abnormal_body_temperature | 0.92744014 |
52 | MP0002127_abnormal_cardiovascular_syste | 0.92249686 |
53 | MP0001661_extended_life_span | 0.91629191 |
54 | MP0006035_abnormal_mitochondrial_morpho | 0.90770886 |
55 | MP0009115_abnormal_fat_cell | 0.90671630 |
56 | MP0008438_abnormal_cutaneous_collagen | 0.86071746 |
57 | * MP0002078_abnormal_glucose_homeostasis | 0.86025489 |
58 | MP0000266_abnormal_heart_morphology | 0.78795686 |
59 | * MP0002118_abnormal_lipid_homeostasis | 0.78550222 |
60 | MP0005275_abnormal_skin_tensile | 0.74704470 |
61 | MP0003879_abnormal_hair_cell | 0.73085703 |
62 | MP0002970_abnormal_white_adipose | 0.72174648 |
63 | MP0003806_abnormal_nucleotide_metabolis | 0.69264931 |
64 | MP0010329_abnormal_lipoprotein_level | 0.68365176 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66165861 |
66 | MP0004147_increased_porphyrin_level | 0.65535115 |
67 | MP0005452_abnormal_adipose_tissue | 0.65411793 |
68 | MP0005165_increased_susceptibility_to | 0.64955221 |
69 | MP0004043_abnormal_pH_regulation | 0.64211013 |
70 | MP0000230_abnormal_systemic_arterial | 0.62698515 |
71 | MP0002909_abnormal_adrenal_gland | 0.61454053 |
72 | MP0000372_irregular_coat_pigmentation | 0.59003189 |
73 | MP0005319_abnormal_enzyme/_coenzyme | 0.58287117 |
74 | MP0003959_abnormal_lean_body | 0.57548074 |
75 | MP0002234_abnormal_pharynx_morphology | 0.55780323 |
76 | MP0001879_abnormal_lymphatic_vessel | 0.55531626 |
77 | MP0001881_abnormal_mammary_gland | 0.53802212 |
78 | MP0003567_abnormal_fetal_cardiomyocyte | 0.53208135 |
79 | MP0001346_abnormal_lacrimal_gland | 0.51665689 |
80 | MP0003045_fibrosis | 0.50859534 |
81 | MP0004134_abnormal_chest_morphology | 0.50854087 |
82 | MP0004142_abnormal_muscle_tone | 0.50653933 |
83 | MP0003566_abnormal_cell_adhesion | 0.50246985 |
84 | MP0005448_abnormal_energy_balance | 0.49813913 |
85 | MP0003948_abnormal_gas_homeostasis | 0.49218089 |
86 | MP0001853_heart_inflammation | 0.48967242 |
87 | MP0005423_abnormal_somatic_nervous | 0.48888959 |
88 | MP0003279_aneurysm | 0.48865677 |
89 | MP0003656_abnormal_erythrocyte_physiolo | 0.46548059 |
90 | MP0002128_abnormal_blood_circulation | 0.46037637 |
91 | MP0005166_decreased_susceptibility_to | 0.46032574 |
92 | MP0005332_abnormal_amino_acid | 0.45696956 |
93 | MP0003191_abnormal_cellular_cholesterol | 0.44291775 |
94 | MP0009780_abnormal_chondrocyte_physiolo | 0.39768853 |
95 | MP0004270_analgesia | 0.38200060 |
96 | MP0003690_abnormal_glial_cell | 0.37959924 |
97 | MP0000609_abnormal_liver_physiology | 0.37490840 |
98 | MP0009840_abnormal_foam_cell | 0.35289985 |
99 | MP0002114_abnormal_axial_skeleton | 0.34002732 |
100 | MP0001299_abnormal_eye_distance/ | 0.33383310 |
101 | MP0008569_lethality_at_weaning | 0.32245783 |
102 | MP0009672_abnormal_birth_weight | 0.32061149 |
103 | MP0004272_abnormal_basement_membrane | 0.28133453 |
104 | MP0010030_abnormal_orbit_morphology | 0.26506656 |
105 | MP0005376_homeostasis/metabolism_phenot | 0.26436930 |
106 | MP0002896_abnormal_bone_mineralization | 0.26256404 |
107 | MP0005083_abnormal_biliary_tract | 0.25129196 |
108 | MP0005058_abnormal_lysosome_morphology | 0.24705799 |
109 | MP0003953_abnormal_hormone_level | 0.24180803 |
110 | MP0001727_abnormal_embryo_implantation | 0.24093924 |
111 | MP0000762_abnormal_tongue_morphology | 0.23775031 |
112 | MP0009250_abnormal_appendicular_skeleto | 0.23560190 |
113 | MP0005167_abnormal_blood-brain_barrier | 0.23560188 |
114 | MP0003329_amyloid_beta_deposits | 0.22734194 |
115 | MP0001943_abnormal_respiration | 0.22168681 |
116 | MP0002638_abnormal_pupillary_reflex | 0.22115344 |
117 | MP0002254_reproductive_system_inflammat | 0.21505370 |
118 | MP0002876_abnormal_thyroid_physiology | 0.21273076 |
119 | MP0003633_abnormal_nervous_system | 0.20666270 |
120 | MP0002066_abnormal_motor_capabilities/c | 0.18878281 |
121 | MP0002734_abnormal_mechanical_nocicepti | 0.18575573 |
122 | MP0008874_decreased_physiological_sensi | 0.17547938 |
123 | MP0002249_abnormal_larynx_morphology | 0.14300973 |
124 | MP0002067_abnormal_sensory_capabilities | 0.14144432 |
125 | MP0004197_abnormal_fetal_growth/weight/ | 0.13629144 |
126 | MP0004381_abnormal_hair_follicle | 0.13038490 |
127 | MP0005410_abnormal_fertilization | 0.12289711 |
128 | MP0004858_abnormal_nervous_system | 0.11907564 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 8.15673513 |
2 | Exercise-induced muscle cramps (HP:0003710) | 7.26081908 |
3 | Muscle fiber inclusion bodies (HP:0100299) | 6.71458044 |
4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.56122828 |
5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.49002378 |
6 | Myoglobinuria (HP:0002913) | 6.41177281 |
7 | Calf muscle hypertrophy (HP:0008981) | 6.30324574 |
8 | Muscle fiber splitting (HP:0003555) | 5.85849475 |
9 | Nemaline bodies (HP:0003798) | 5.75210698 |
10 | Difficulty running (HP:0009046) | 5.53680842 |
11 | Type 1 muscle fiber predominance (HP:0003803) | 5.38801391 |
12 | Rhabdomyolysis (HP:0003201) | 5.18425643 |
13 | Hyporeflexia of lower limbs (HP:0002600) | 5.10959676 |
14 | Sudden death (HP:0001699) | 5.07302745 |
15 | Distal arthrogryposis (HP:0005684) | 4.75072320 |
16 | Increased connective tissue (HP:0009025) | 4.71328292 |
17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.68530216 |
18 | Abnormality of the calf musculature (HP:0001430) | 4.61846921 |
19 | Muscle stiffness (HP:0003552) | 4.43431484 |
20 | EMG: myopathic abnormalities (HP:0003458) | 4.42560844 |
21 | Myopathic facies (HP:0002058) | 4.32531289 |
22 | Subaortic stenosis (HP:0001682) | 4.23353252 |
23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.23353252 |
24 | Myotonia (HP:0002486) | 4.14605127 |
25 | Round ear (HP:0100830) | 4.12996562 |
26 | Ventricular tachycardia (HP:0004756) | 3.99652590 |
27 | Ulnar deviation of the wrist (HP:0003049) | 3.78480905 |
28 | Asymmetric septal hypertrophy (HP:0001670) | 3.63539290 |
29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.42430895 |
30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.39561245 |
31 | Lipoatrophy (HP:0100578) | 3.37106542 |
32 | Difficulty climbing stairs (HP:0003551) | 3.21921892 |
33 | Calcaneovalgus deformity (HP:0001848) | 3.17777711 |
34 | Neck muscle weakness (HP:0000467) | 3.13389934 |
35 | Atrial fibrillation (HP:0005110) | 3.00150006 |
36 | Areflexia of lower limbs (HP:0002522) | 2.92901977 |
37 | Dilated cardiomyopathy (HP:0001644) | 2.91038806 |
38 | Absent phalangeal crease (HP:0006109) | 2.88415289 |
39 | Deformed tarsal bones (HP:0008119) | 2.88011827 |
40 | Rimmed vacuoles (HP:0003805) | 2.87266623 |
41 | Primary atrial arrhythmia (HP:0001692) | 2.78983909 |
42 | Right ventricular cardiomyopathy (HP:0011663) | 2.76903633 |
43 | Bundle branch block (HP:0011710) | 2.73397760 |
44 | Supraventricular tachycardia (HP:0004755) | 2.67899267 |
45 | Palpitations (HP:0001962) | 2.65910567 |
46 | Supraventricular arrhythmia (HP:0005115) | 2.63213016 |
47 | Weak cry (HP:0001612) | 2.62627680 |
48 | Fetal akinesia sequence (HP:0001989) | 2.62134329 |
49 | Frequent falls (HP:0002359) | 2.53199528 |
50 | Distal lower limb muscle weakness (HP:0009053) | 2.50982895 |
51 | Abnormality of the calcaneus (HP:0008364) | 2.44461738 |
52 | Hyperkalemia (HP:0002153) | 2.43767463 |
53 | Muscular dystrophy (HP:0003560) | 2.40186356 |
54 | Heart block (HP:0012722) | 2.39537886 |
55 | Increased muscle lipid content (HP:0009058) | 2.37718427 |
56 | Facial diplegia (HP:0001349) | 2.36932893 |
57 | Abnormal finger flexion creases (HP:0006143) | 2.36061499 |
58 | Prolonged QT interval (HP:0001657) | 2.35101006 |
59 | Oligomenorrhea (HP:0000876) | 2.33904328 |
60 | Ketoacidosis (HP:0001993) | 2.32614396 |
61 | Hypoplastic ischia (HP:0003175) | 2.30052373 |
62 | Ventricular arrhythmia (HP:0004308) | 2.28728244 |
63 | Abnormal atrioventricular conduction (HP:0005150) | 2.25960614 |
64 | Hyperglycinuria (HP:0003108) | 2.25045492 |
65 | Progressive muscle weakness (HP:0003323) | 2.24243588 |
66 | Generalized muscle weakness (HP:0003324) | 2.23749108 |
67 | Hepatic necrosis (HP:0002605) | 2.23097497 |
68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.22605236 |
69 | Syncope (HP:0001279) | 2.21568326 |
70 | Hypoglycemic coma (HP:0001325) | 2.21410783 |
71 | EMG: neuropathic changes (HP:0003445) | 2.21067442 |
72 | Atrioventricular block (HP:0001678) | 2.20914018 |
73 | Proximal amyotrophy (HP:0007126) | 2.20635624 |
74 | Malignant hyperthermia (HP:0002047) | 2.16927551 |
75 | Gowers sign (HP:0003391) | 2.16519599 |
76 | Limb-girdle muscle atrophy (HP:0003797) | 2.15582843 |
77 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.15010114 |
78 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12610234 |
79 | Waddling gait (HP:0002515) | 2.11909537 |
80 | Dicarboxylic aciduria (HP:0003215) | 2.09611391 |
81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09611391 |
82 | Hip contracture (HP:0003273) | 2.07904320 |
83 | Abnormality of the ischium (HP:0003174) | 2.02679014 |
84 | Scapular winging (HP:0003691) | 2.01783273 |
85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01121145 |
86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99352127 |
87 | Abnormality of alanine metabolism (HP:0010916) | 1.99352127 |
88 | Hyperalaninemia (HP:0003348) | 1.99352127 |
89 | Limb-girdle muscle weakness (HP:0003325) | 1.98492112 |
90 | Abnormality of the foot musculature (HP:0001436) | 1.97907025 |
91 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.97880837 |
92 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.97880837 |
93 | Exercise intolerance (HP:0003546) | 1.93438358 |
94 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.93326592 |
95 | Distal lower limb amyotrophy (HP:0008944) | 1.92917903 |
96 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.92688494 |
97 | Spinal rigidity (HP:0003306) | 1.90923052 |
98 | Pelvic girdle muscle weakness (HP:0003749) | 1.90838374 |
99 | Ketosis (HP:0001946) | 1.90806142 |
100 | Shoulder girdle muscle weakness (HP:0003547) | 1.87397314 |
101 | Acute necrotizing encephalopathy (HP:0006965) | 1.87285990 |
102 | Hypoalphalipoproteinemia (HP:0003233) | 1.86035009 |
103 | Lower limb amyotrophy (HP:0007210) | 1.85610661 |
104 | Foot dorsiflexor weakness (HP:0009027) | 1.84402775 |
105 | Abnormality of the neuromuscular junction (HP:0003398) | 1.84125431 |
106 | Fatigable weakness (HP:0003473) | 1.84125431 |
107 | Paralysis (HP:0003470) | 1.83595861 |
108 | Slender build (HP:0001533) | 1.82654303 |
109 | Abnormality of glycine metabolism (HP:0010895) | 1.82563882 |
110 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82563882 |
111 | Bulbar palsy (HP:0001283) | 1.81535875 |
112 | Hepatocellular necrosis (HP:0001404) | 1.80676035 |
113 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.79041008 |
114 | Nonprogressive disorder (HP:0003680) | 1.78396780 |
115 | Ragged-red muscle fibers (HP:0003200) | 1.68741003 |
116 | Type 2 muscle fiber atrophy (HP:0003554) | 1.66270763 |
117 | Long clavicles (HP:0000890) | 1.65974680 |
118 | Metatarsus adductus (HP:0001840) | 1.63824848 |
119 | Ulnar deviation of finger (HP:0009465) | 1.59572442 |
120 | Popliteal pterygium (HP:0009756) | 1.59233274 |
121 | Muscle fiber atrophy (HP:0100295) | 1.57730765 |
122 | Increased intramyocellular lipid droplets (HP:0012240) | 1.53938389 |
123 | Easy fatigability (HP:0003388) | 1.37368994 |
124 | Congenital hip dislocation (HP:0001374) | 1.34314833 |
125 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.32828522 |
126 | Limited hip movement (HP:0008800) | 1.32340210 |
127 | Steppage gait (HP:0003376) | 1.30392911 |
128 | Achilles tendon contracture (HP:0001771) | 1.26379413 |
129 | Fatigue (HP:0012378) | 1.24451339 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 6.10279729 |
2 | OBSCN | 5.75711525 |
3 | PHKG2 | 5.15306238 |
4 | PHKG1 | 5.15306238 |
5 | TRIB3 | 3.57656352 |
6 | PDK4 | 3.52897934 |
7 | PDK3 | 3.52897934 |
8 | BCKDK | 2.76233612 |
9 | NME1 | 2.69660037 |
10 | PDK2 | 2.35270339 |
11 | PINK1 | 2.26880283 |
12 | DMPK | 2.23307840 |
13 | LMTK2 | 2.01927721 |
14 | NEK1 | 1.94849633 |
15 | PIK3CA | 1.94696808 |
16 | MAP2K3 | 1.85107110 |
17 | PIK3CG | 1.78974459 |
18 | PKN2 | 1.69538140 |
19 | MAP3K7 | 1.65865739 |
20 | MUSK | 1.57737681 |
21 | CAMK1D | 1.51210784 |
22 | MAPK12 | 1.45813838 |
23 | SIK1 | 1.41568989 |
24 | PRKAA2 | 1.37700940 |
25 | CAMK1G | 1.34270941 |
26 | MYLK | 1.19806801 |
27 | TIE1 | 1.12599626 |
28 | PRKAA1 | 1.09476677 |
29 | STK24 | 1.08844084 |
30 | MAP2K4 | 0.90869246 |
31 | MAP3K13 | 0.89612806 |
32 | RIPK1 | 0.87420089 |
33 | MOS | 0.85713221 |
34 | DYRK1B | 0.82260334 |
35 | MARK1 | 0.79417192 |
36 | ILK | 0.78233971 |
37 | CCNB1 | 0.78070893 |
38 | INSRR | 0.77209909 |
39 | NEK9 | 0.75727885 |
40 | PRKD1 | 0.75481224 |
41 | TGFBR2 | 0.70904986 |
42 | MAP2K6 | 0.70189572 |
43 | EPHB1 | 0.65346633 |
44 | MAPKAPK3 | 0.64791137 |
45 | TRPM7 | 0.64230147 |
46 | LIMK1 | 0.63361062 |
47 | ERBB3 | 0.61645815 |
48 | CAMK2D | 0.57759331 |
49 | MAP3K3 | 0.57696453 |
50 | PDPK1 | 0.54201486 |
51 | TBK1 | 0.51259833 |
52 | PTK6 | 0.50918951 |
53 | GRK7 | 0.50336809 |
54 | PKN1 | 0.49733549 |
55 | ROCK1 | 0.46297125 |
56 | PRPF4B | 0.46118091 |
57 | ERN1 | 0.45874637 |
58 | PDK1 | 0.45814653 |
59 | MAPK11 | 0.45222083 |
60 | CAMK2G | 0.44397776 |
61 | ZAK | 0.44239438 |
62 | PDGFRA | 0.44147247 |
63 | PAK3 | 0.42101049 |
64 | AKT2 | 0.39816462 |
65 | STK38L | 0.38537500 |
66 | MAP3K5 | 0.37051600 |
67 | PRKACG | 0.37033800 |
68 | STK38 | 0.34593969 |
69 | MARK3 | 0.34447166 |
70 | PRKACB | 0.34090288 |
71 | SGK3 | 0.33688740 |
72 | SGK2 | 0.31832321 |
73 | TAOK2 | 0.30936630 |
74 | CAMK1 | 0.30613348 |
75 | PRKACA | 0.30470760 |
76 | ZAP70 | 0.30198258 |
77 | PRKCH | 0.30145086 |
78 | PTK2B | 0.30031079 |
79 | FGFR3 | 0.29518202 |
80 | SGK1 | 0.28588398 |
81 | MAP3K6 | 0.28580105 |
82 | MARK2 | 0.26908498 |
83 | RPS6KB1 | 0.26773335 |
84 | CAMK2B | 0.26696891 |
85 | FLT3 | 0.26325142 |
86 | LATS1 | 0.25987991 |
87 | CDK19 | 0.25952824 |
88 | TAOK1 | 0.25769120 |
89 | JAK1 | 0.25610581 |
90 | MAPK13 | 0.25490826 |
91 | ICK | 0.25277636 |
92 | PRKD3 | 0.25174744 |
93 | RPS6KA3 | 0.24371868 |
94 | CAMK4 | 0.23907362 |
95 | JAK2 | 0.23075387 |
96 | MAPK10 | 0.22950874 |
97 | MAP3K10 | 0.22836958 |
98 | RET | 0.22796379 |
99 | MAPK7 | 0.22571380 |
100 | MTOR | 0.22338606 |
101 | TNK2 | 0.21577367 |
102 | RPS6KA1 | 0.20461112 |
103 | MAPK4 | 0.19314706 |
104 | PRKG1 | 0.18578440 |
105 | CAMK2A | 0.18535680 |
106 | MAP2K1 | 0.17682547 |
107 | RAF1 | 0.17001361 |
108 | WNK1 | 0.16946137 |
109 | ROCK2 | 0.16153006 |
110 | RPS6KL1 | 0.16052040 |
111 | RPS6KC1 | 0.16052040 |
112 | MAP3K1 | 0.15242504 |
113 | SGK223 | 0.15004471 |
114 | SGK494 | 0.15004471 |
115 | LRRK2 | 0.13642718 |
116 | RPS6KB2 | 0.13418488 |
117 | KSR2 | 0.13149249 |
118 | STK11 | 0.12505653 |
119 | EEF2K | 0.12106959 |
120 | FGFR4 | 0.12071351 |
121 | PAK6 | 0.11717945 |
122 | LATS2 | 0.11639799 |
123 | RPS6KA6 | 0.10860595 |
124 | KSR1 | 0.10830838 |
125 | MAP3K11 | 0.09853137 |
126 | ARAF | 0.08833166 |
127 | RPS6KA2 | 0.07315511 |
128 | PRKCQ | 0.07222134 |
129 | DAPK2 | 0.06426091 |
130 | MAPK3 | 0.04280504 |
131 | GSK3B | 0.03260771 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.56992382 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.04822720 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.93708014 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.18401638 |
5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.95086227 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.92551745 |
7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.89588012 |
8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.87256183 |
9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.71820774 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70821457 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.51726132 |
12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.27357923 |
13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.13154681 |
14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10995293 |
15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.87767010 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80506971 |
17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.74191625 |
18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.73022589 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.70925963 |
20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.68245603 |
21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.59186920 |
22 | Insulin resistance_Homo sapiens_hsa04931 | 1.59045845 |
23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56644577 |
24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53882265 |
25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.50384631 |
26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.42427852 |
27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42388718 |
28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.41579971 |
29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.38167864 |
30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29923611 |
31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.27091087 |
32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25860605 |
33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22509760 |
34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15746975 |
35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10438987 |
36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07113575 |
37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04107542 |
38 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98060185 |
39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.96519530 |
40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96285673 |
41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90563938 |
42 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88397178 |
43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87578337 |
44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86911857 |
45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83976106 |
46 | Peroxisome_Homo sapiens_hsa04146 | 0.80367737 |
47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69922634 |
48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69689911 |
49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69083162 |
50 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69028676 |
51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67951728 |
52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67768668 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65767161 |
54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64989822 |
55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64646989 |
56 | Renin secretion_Homo sapiens_hsa04924 | 0.64017966 |
57 | Focal adhesion_Homo sapiens_hsa04510 | 0.62230813 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59940865 |
59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59687410 |
60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59410104 |
61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58493494 |
62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56394079 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 0.55246006 |
64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53566495 |
65 | Tight junction_Homo sapiens_hsa04530 | 0.50593269 |
66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42642821 |
67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41661242 |
68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39553510 |
69 | Glioma_Homo sapiens_hsa05214 | 0.38889507 |
70 | Long-term depression_Homo sapiens_hsa04730 | 0.38419816 |
71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37626829 |
72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35498610 |
73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35350598 |
74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35174337 |
75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33619155 |
76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32377457 |
77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31624972 |
78 | Insulin secretion_Homo sapiens_hsa04911 | 0.29983042 |
79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28097659 |
80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27963438 |
81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26709591 |
82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.26333935 |
83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26201802 |
84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25845929 |
85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25582601 |
86 | Amoebiasis_Homo sapiens_hsa05146 | 0.24427873 |
87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24292508 |
88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23596067 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.22326837 |
90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22067724 |
91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21852574 |
92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21370686 |
93 | Adherens junction_Homo sapiens_hsa04520 | 0.20406713 |
94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.20280110 |
95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19876701 |
96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19290496 |
97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.18345200 |
98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18141011 |
99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.14571465 |
100 | ABC transporters_Homo sapiens_hsa02010 | 0.14119954 |
101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.13811528 |
102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13773205 |
103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.13618455 |
104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.13564900 |
105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13510170 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12975756 |
107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12785599 |
108 | Bile secretion_Homo sapiens_hsa04976 | 0.12695895 |
109 | Salivary secretion_Homo sapiens_hsa04970 | 0.12467526 |
110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12316613 |
111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.11511395 |
112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09491562 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.09372030 |
114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06522762 |
115 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.04734008 |
116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.04624330 |
117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.03702000 |
118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.02548135 |